99mTc-MIRC208 SPECT/CT Imaging for HER2-Positive Cancer Patients

NCT04591652 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Peking University Cancer Hospital & Institute